Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Stroke. 2019 May 14;50(6):1519–1524. doi: 10.1161/STROKEAHA.118.024249

Table 3.

Crude and Multivariable Models of the Association of Ethnicity and Medication Non-adherence 90 days post-stroke

Multivariable Models
Antiplatelets (n=914) Anticoagulants (n=173) Antihyperten-sives (n=917) Statins (n=819) Antidepress-ants (n=177)
OR
(95% CI)		 OR
(95% CI)		 OR
(95% CI)		 OR
(95% CI)		 OR
(95% CI)
MA (v NHW) 0.92
(0.64–1.33)		 1.13
(0.43–2.97)		 1.00
(0.67–1.49)		 1.15
(0.76–1.73)		 1.20
(0.45–3.22)
Age 0.98
(0.96–1.00)		 0.97
(0.94–1.02)		 0.97
(0.95–0.99)		 0.98
(0.96–1.00)		 0.97
(0.93–1.02)
Female (v Male) 0.83
(0.60–1.15)		 1.11
(0.47–2.62)		 0.94
(0.66–1.33)		 1.07
(0.74–1.54)		 1.01
(0.39–2.60)
NIHSS 0.99
(0.95–1.03)		 0.93
(0.85–1.02)		 0.98
(0.94–1.02)		 0.97
(0.93–1.01)		 1.00
(0.92–1.08)
Private and Medicare
(v none and Medicaid)		 0.6
(0.38–0.95)		 1.13
(0.24–5.33)		 0.71
(0.43–1.16)		 0.59
(0.35–0.98)		 0.27
(0.08–0.84)
HS education 1.02
(0.61–1.71)		 1.55
(0.36–6.76)		 1.20
(0.70–2.05)		 1.29
(0.73–2.27)		 1.49
(0.27–8.18)
Vocational/some college 0.96
(0.54–1.72)		 1.43
(0.29–7.12)		 0.74
(0.39–1.40)		 0.79
(0.40–1.53)		 1.01
(0.15–6.76)
College or more 0.72
(0.36–1.43)		 1.59
(0.25–10.22)		 0.76
(0.36–1.60)		 0.81
(0.37–1.77)		 0.75
(0.08–7.14)
Crude: MA (v NHW)* 1.04
(0.75–1.46)		 1.04
(0.46–2.36)		 1.23
(0.86–1.78)		 1.34
(0.92–1.96)		 1.26
(0.52–3.03)

MA=Mexican American, NHW=Non-Hispanic White, NIHSS=National Institute of Health Stroke Scale, HS= High school

No high school is the reference category for education

Adherence defined as never missing a dose

Estimates obtained from a logistic regression

*

Obtained from crude model and limited to cases with complete data on variables included in adjusted model